Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
CytoDyn Inc (CYDY) Message Board
Search
Search Type
Board
Post
Member
FACT: “PRO 140 has completed 7 clinical trials o
Message Board
Public Reply
|
Private Reply
|
Keep
|
Replies
(0)
Post New Msg
Edit Msg
(
) |
Previous
|
Next
Post#
of 148288
(Total Views: 647)
Posted On: 03/02/2022 11:38:00 AM
Posted By:
Evil Rabbit
Re:
brentie
#119381
FACT: “PRO 140 has completed 7 clinical trials over the past decade and has one of the best safety profiles for a monoclonal antibody with NO SAEs in over 400 patients across 8 clinical trials.”
FDA: “WE DON’T KNOW IF IT’S SAFE!!!”
(8)
(0)
CytoDyn Inc (CYDY) Stock Research Links
CYDY Message Board
Company Profile
Time & Sales
Recent News
Filings
Financials
Buy Rating
Newer
Older
Scroll down for more posts ▼
